Gilles Defer Selected Research

Gilles Defer Research Topics

Disease

24	Multiple Sclerosis 03/2024 - 03/2011
8	Relapsing-Remitting Multiple Sclerosis 04/2023 - 02/2016
5	Progressive Multifocal Leukoencephalopathy 04/2023 - 12/2016
4	Neoplasms (Cancer) 02/2024 - 07/2011
3	Stroke (Strokes) 11/2011 - 05/2011
2	Cognitive Dysfunction 01/2019 - 04/2016
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 11/2012
2	Alzheimer Disease (Alzheimer's Disease) 04/2016 - 11/2012
2	Parkinson Disease (Parkinson's Disease) 06/2014 - 08/2003
2	Ischemic Stroke 11/2011 - 10/2011
1	Liver Diseases (Liver Disease) 10/2023
1	Chemical and Drug Induced Liver Injury 10/2023
1	Sudden Infant Death (SID) 04/2023
1	Transverse Myelitis (Necrotizing Myelitis) 12/2022
1	Skin Neoplasms (Skin Cancer) 01/2021
1	Disease Progression 01/2021
1	Pain (Aches) 09/2020
1	Infections 01/2020
1	COVID-19 01/2020
1	Optic Neuritis (Retrobulbar Neuritis) 01/2018
1	Fatigue 11/2017
1	Dementia (Dementias) 06/2014
1	Neuromyelitis Optica (Devic's Disease) 01/2014
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 11/2012
1	Hyperglycemia 11/2012
1	Inflammation (Inflammations) 11/2012
1	Neuroinflammatory Diseases 11/2012
1	Myelitis 08/2012
1	CADASIL 08/2012
1	Thrombotic Stroke 10/2011
1	Infarction (Infarctions) 10/2011
1	Autoimmune Diseases (Autoimmune Disease) 03/2011

Drug/Important Bio-Agent (IBA)

14	Natalizumab (Tysabri)FDA Link 04/2023 - 03/2012
6	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 04/2014
4	Biotin (Vitamin H)FDA Link 01/2021 - 11/2016
3	teriflunomideIBA 01/2021 - 01/2019
2	Cladribine FDA LinkGeneric 11/2023 - 10/2023
2	TabletsIBA 11/2023 - 10/2023
2	nitazoxanide (NTZ)FDA Link 01/2022 - 01/2021
2	Dimethyl FumarateIBA 01/2021 - 01/2019
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2011 - 10/2011
1	Ad26COVS1IBA 12/2022
1	VaccinesIBA 12/2022
1	Alemtuzumab (Campath)FDA Link 01/2021
1	ocrelizumabIBA 01/2021
1	Glatiramer Acetate (Copaxone)FDA Link 01/2021
1	InterferonsIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2019
1	P-SelectinIBA 01/2017
1	N-Methylaspartate (NMDA)IBA 04/2016
1	Memantine (Namenda)FDA Link 04/2016
1	Glutamate Receptors (Glutamate Receptor)IBA 04/2016
1	Rivastigmine (Exelon)FDA LinkGeneric 06/2014
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2014
1	Ethanol (Ethyl Alcohol)IBA 11/2012
1	Contrast MediaIBA 11/2012
1	Amyloid (Amyloid Fibrils)IBA 11/2012
1	Oligoclonal BandsIBA 08/2012
1	GadoliniumIBA 08/2012
1	Integrin alpha4beta1 (VLA-4)IBA 03/2012
1	Monoclonal AntibodiesIBA 03/2012
1	Integrin alpha4IBA 03/2012
1	Thrombin FDA Link 10/2011
1	Anesthetics (Anesthetic Agents)IBA 10/2011
1	Ketamine FDA LinkGeneric 10/2011
1	Immunologic Factors (Immunomodulators)IBA 07/2011
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 03/2011
1	fluorodopa F 18IBA 08/2003
1	LigandsIBA 08/2003
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 08/2003
1	Dopamine (Intropin)FDA LinkGeneric 08/2003

Therapy/Procedure

15	Therapeutics 03/2024 - 05/2011
1	Cognitive Training 10/2019
1	Length of Stay 11/2011
1	Home Nursing (Nursing, Home) 11/2011
1	Transplantation 08/2003